Healthcare provider profile · identity verified

William W Devine, MD

Family Practice · WATERTOWN, SD · NPI 1376522854

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	417	83
Atorvastatin Calcium	Atorvastatin Calcium	366	95
Lisinopril	Lisinopril	292	77
Potassium Chloride	Potassium Chloride	260	56
Sertraline Hcl	Sertraline Hcl	258	38
Pantoprazole Sodium	Pantoprazole Sodium	244	62
Amlodipine Besylate	Amlodipine Besylate	242	74
Tamsulosin Hcl	Tamsulosin Hcl	242	49
Omeprazole	Omeprazole	235	52
Warfarin Sodium	Warfarin Sodium	206	26
Metoprolol Succinate	Metoprolol Succinate	197	53
Gabapentin	Gabapentin	194	49
Spironolactone	Spironolactone	174	41
Losartan Potassium	Losartan Potassium	167	47
Trazodone Hcl	Trazodone Hcl	161	35
Rosuvastatin Calcium	Rosuvastatin Calcium	155	50
Simvastatin	Simvastatin	146	34
Mirtazapine	Mirtazapine	136	22
Bumetanide	Bumetanide	129	22
Furosemide	Furosemide	126	37
Alprazolam	Alprazolam	119	25
Metoprolol Tartrate	Metoprolol Tartrate	117	32
Metformin Hcl	Metformin Hcl	116	35
Allopurinol	Allopurinol	112	33
Carvedilol	Carvedilol	105	25
Clopidogrel	Clopidogrel Bisulfate	105	30
Clonazepam	Clonazepam	102	16
Glipizide	Glipizide	102	22
Prednisone	Prednisone	102	67
Bisoprolol Fumarate	Bisoprolol Fumarate	100	24
Lorazepam	Lorazepam	89	21
Donepezil Hcl	Donepezil Hcl	82	19
Sucralfate	Sucralfate	81	22
Carbidopa-Levodopa	Carbidopa/Levodopa	80	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	80	17
Ozempic	Semaglutide	80	15
Tramadol Hcl	Tramadol Hcl	79	21
Meloxicam	Meloxicam	77	28
Pioglitazone Hcl	Pioglitazone Hcl	75	17
Quetiapine Fumarate	Quetiapine Fumarate	73	13
Torsemide	Torsemide	72	suppressed
Citalopram Hbr	Citalopram Hydrobromide	70	17
Terazosin Hcl	Terazosin Hcl	70	18
Eliquis	Apixaban	67	13
Famotidine	Famotidine	67	11
Fluoxetine Hcl	Fluoxetine Hcl	67	15
Albuterol Sulfate Hfa	Albuterol Sulfate	64	28
Levetiracetam	Levetiracetam	60	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	59	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	12
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	58	18
Escitalopram Oxalate	Escitalopram Oxalate	58	11
Diclofenac Sodium	Diclofenac Sodium	55	23
Oxybutynin Chloride Er	Oxybutynin Chloride	55	14
Digoxin	Digoxin	53	15
Cefdinir	Cefdinir	52	48
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	52	suppressed
Montelukast Sodium	Montelukast Sodium	51	11
Celecoxib	Celecoxib	49	14
Dutasteride	Dutasteride	49	11
Hydrochlorothiazide	Hydrochlorothiazide	49	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	12
Januvia	Sitagliptin Phosphate	44	suppressed
Atenolol	Atenolol	41	13
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	41	suppressed
Ezetimibe	Ezetimibe	40	12
Hydralazine Hcl	Hydralazine Hcl	40	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	40	16
Nitroglycerin Patch	Nitroglycerin	39	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Jardiance	Empagliflozin	38	suppressed
Duloxetine Hcl	Duloxetine Hcl	37	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	36	28
Metolazone	Metolazone	36	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	36	11
Lactulose	Lactulose	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Xarelto	Rivaroxaban	34	11
Azithromycin	Azithromycin	33	25
Ipratropium Bromide	Ipratropium Bromide	33	13
Fentanyl	Fentanyl	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	11
Buspirone Hcl	Buspirone Hcl	31	suppressed
Jantoven	Warfarin Sodium	30	suppressed
Ondansetron Odt	Ondansetron	30	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	29	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Entresto	Sacubitril/Valsartan	26	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Repaglinide	Repaglinide	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	18
Amoxicillin	Amoxicillin	25	16
Cholestyramine	Cholestyramine (With Sugar)	24	suppressed
Finasteride	Finasteride	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Levofloxacin	Levofloxacin	22	18
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Fluconazole	Fluconazole	20	11
Olanzapine	Olanzapine	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Phenobarbital	Phenobarbital	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Dupixent Syringe	Dupilumab	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Acetazolamide	Acetazolamide	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Humulin R	Insulin Regular, Human	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Diazepam	Diazepam	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error